Cargando…

Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design

INTRODUCTION: Cotrimoxazole (CTX) prophylaxis is recommended by the World Health Organisation for HIV infected persons. However, once HIV infected patients have commenced ART in resource limited settings, the benefits of continued CTX prophylaxis are not known. The few studies that investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anywaine, Zacchaeus, Abaasa, Andrew, Levin, Jonathan, Kasirye, Ronnie, Kamali, Anatoli, Grosskurth, Heiner, Munderi, Paula, Nunn, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542218/ https://www.ncbi.nlm.nih.gov/pubmed/26009024 http://dx.doi.org/10.1016/j.cct.2015.05.015

Ejemplares similares

Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial
por: Anywaine, Zacchaeus, et al.
Publicado: (2018)

Exit interviews administered to patients participating in the COSTOP placebo controlled randomised trial in Uganda
por: Nunn, Andrew, et al.
Publicado: (2016)

Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study
por: Kasirye, Ronnie P., et al.
Publicado: (2016)

Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled study
por: Kasirye, Ronnie, et al.
Publicado: (2016)

Effect of Stopping Cotrimoxazole Preventive Therapy on Microbial Translocation and Inflammatory Markers Among Human Immunodeficiency Virus–Infected Ugandan Adults on Antiretroviral Therapy: The COSTOP Trial Immunology Substudy
por: Kyosiimire-Lugemwa, Jacqueline, et al.
Publicado: (2020)

Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults
por: Kasirye, Ronnie P., et al.
Publicado: (2017)

Reasons for participating in a randomised clinical trial: The volunteers' voices in the COSTOP trial in Uganda
por: Ssali, Agnes, et al.
Publicado: (2017)

Effect of cotrimoxazole prophylaxis on malaria occurrence in HIV-infected patients on antiretroviral therapy in sub-Saharan Africa*
por: Kasirye, R, et al.
Publicado: (2015)

Uptake of hormonal contraceptives and correlates of uptake in a phase III clinical trial in rural South Western Uganda
por: Abaasa, Andrew, et al.
Publicado: (2017)

Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda
por: Abaasa, Andrew, et al.
Publicado: (2013)

Increased malaria parasitaemia among adults living with HIV who have discontinued cotrimoxazole prophylaxis in Kitgum district, Uganda
por: Orishaba, Philip, et al.
Publicado: (2020)

HIV Incidence and Risk Factors for Acquisition in HIV Discordant Couples in Masaka, Uganda: An HIV Vaccine Preparedness Study
por: Ruzagira, Eugene, et al.
Publicado: (2011)

Impact of Anti-Retroviral Treatment and Cotrimoxazole Prophylaxis on Helminth Infections in HIV-Infected Patients in Lambaréné, Gabon
por: Janssen, Saskia, et al.
Publicado: (2015)

Brief counselling after home‐based HIV counselling and testing strongly increases linkage to care: a cluster‐randomized trial in Uganda
por: Ruzagira, Eugene, et al.
Publicado: (2017)

Factors associated with uptake of home-based HIV counselling and testing and HIV care services among identified HIV-positive persons in Masaka, Uganda
por: Ruzagira, Eugene, et al.
Publicado: (2018)

The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis
por: Juma, Dennis W., et al.
Publicado: (2019)

An open-label cluster randomised trial to evaluate the effectiveness of a counselling intervention on linkage to care among HIV-infected patients in Uganda: Study design
por: Ruzagira, Eugene, et al.
Publicado: (2016)

National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and Links
por: Hutchinson, Eleanor, et al.
Publicado: (2011)

HIV-1 Transmission within Marriage in Rural Uganda: A Longitudinal Study
por: Biraro, Samuel, et al.
Publicado: (2013)

Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial
por: Polyak, Christina S., et al.
Publicado: (2016)

Prevalence and Incidence of HIV in a Rural Community-Based HIV Vaccine Preparedness Cohort in Masaka, Uganda
por: Ruzagira, Eugene, et al.
Publicado: (2011)

Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials: a case control study
por: Mayanja, Yunia, et al.
Publicado: (2020)

Cotrimoxazole Prophylaxis and Tuberculosis Risk among People Living with HIV
por: Hoffmann, Christopher J., et al.
Publicado: (2014)

Cotrimoxazole prophylaxis and antiretroviral therapy: an observational cohort study in China
por: Cheng, Wei, et al.
Publicado: (2015)

Effect of HSV-2 on population-level trends in HIV incidence in Uganda between 1990 and 2007
por: Biraro, Samuel, et al.
Publicado: (2013)

Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV
por: Ku, Stephane Wen‐Wei, et al.
Publicado: (2019)

Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe
por: Medina Lara, Antonieta, et al.
Publicado: (2012)

Cotrimoxazole Prophylaxis Specifically Selects for Cotrimoxazole Resistance in Streptococcus mutans and Streptococcus sobrinus with Varied Polymorphisms in the Target Genes folA and folP
por: William, Buwembo, et al.
Publicado: (2012)

Retention of adults from fishing communities in an HIV vaccine preparedness study in Masaka, Uganda
por: Bahemuka, Ubaldo Mushabe, et al.
Publicado: (2019)

Safety and Immunogenicity of a 2-Dose Heterologous Vaccination Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Uganda and Tanzania
por: Anywaine, Zacchaeus, et al.
Publicado: (2019)

Factors associated with vaccination completion and retention among HIV negative female sex workers enrolled in a simulated vaccine efficacy trial in Kampala, Uganda
por: Mayanja, Yunia, et al.
Publicado: (2019)

The health system burden of chronic disease care: an estimation of provider costs of selected chronic diseases in Uganda
por: Settumba, Stella Nalukwago, et al.
Publicado: (2015)

Linking HIV-Infected TB Patients to Cotrimoxazole Prophylaxis and Antiretroviral Treatment in India
por: Raizada, Neeraj, et al.
Publicado: (2009)

Factors Associated with Coverage of Cotrimoxazole Prophylaxis in HIV-Exposed Children in South Africa
por: Moodley, Dhayendre, et al.
Publicado: (2013)

Feasibility of establishing an HIV vaccine preparedness cohort in a population of the Uganda Police Force: Lessons learnt from a prospective study
por: Bahemuka, Ubaldo Mushabe, et al.
Publicado: (2020)

Factors associated with dropout in a long term observational cohort of fishing communities around lake Victoria, Uganda
por: Abaasa, Andrew, et al.
Publicado: (2015)

High Levels of Persistent Problem Drinking in Women at High Risk for HIV in Kampala, Uganda: A Prospective Cohort Study
por: Weiss, Helen A., et al.
Publicado: (2016)

Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis
por: Prendergast, Andrew J., et al.
Publicado: (2016)

Effect of Seasonal Variation on Adult Clinical Laboratory Parameters in Rwanda, Zambia, and Uganda: Implications for HIV Biomedical Prevention Trials
por: Ruzagira, Eugene, et al.
Publicado: (2014)

Feasibility of conducting HIV combination prevention interventions in fishing communities in Uganda: A pilot cluster randomised trial
por: Kuteesa, Monica O., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fo79glmi79o612cg8pa0h119e6